Of the Field

Advocacy Day 2026

E

ach year Life Sciences Pennsylvania provides a platform for member companies to come to Harrisburg, receive a short briefing on the latest issues, and attend meetings with key legislators and staff. Advocacy Day 2026 is an opportunity for individuals and organizations in the life sciences to share their stories and support with legislators, fostering educat…

Visit the official siteRegister
40Voices
0Underwriters
0Exhibitors
34On the bill · sessions
39Companies · in total
§I

The Voices

Programmed at Advocacy, in alphabetical order.
Alyssa Johnson
Director Business Development & Analytics · Harmony Biosciences
Benjamin R. Cowen
President & CEO · TicTwo Therapeutics
Brian Hart
COO & Co-Founder · RheumaGen
Caroll Neubauer
Executive Advisor · Water Street Healthcare Partners
Charles Swindell
CEO · Glycotest
Chris Burns
Principal · BBC Pharma Advisory
Chris Molineaux
President & CEO · Life Sciences Pennsylvania
Christine Rohan
CEO · Vasowatch
David Rappaport
Senior Vice President, Corporate Development, Strategy and Integration · OraSure Technologies
Duccio Medini, PhD
Chief Science & Technology Officer · BioForge
Eric B. Kmiec
Founder & CEO · CorriXR Therapeutics
Frank Leonard
President · Novocure
Gerri Henwood
President & CEO · Malvern Consulting Group
Gilles Besin, PhD
Chief Scientific Officer · Orbital Therapeutics
Harvey D. Homan
CEO · MetasTx
Heather Callahan
CEO · Swan Neurotech
Jay Batchu
Associate/EIR · Xontogeny
Jeannie Rojas
Senior Director, Business Development & Licensing · GSK
Jesse Hwang, PhD
Associate Director, Search & Evaluation (East North America) · Johnson & Johnson
John Sanders
Director, Enabling Technologies Search and Evaluation, Business Development & Licensing · Merck
John Welsh
Co-Founder & CSO · ChyloMetis
Jonathan Andrews
Director, Business Development · B Braun

— and 18 more, by name unsung —

§III

The Programme

Selected from 34 sessions on the bill.
  • 10:00am - 10:20am

    Entrepreneur Arena: DermaBio

    Entrepreneur Arena
  • 10:00am - 10:20am

    Reverse Pitch Presentation: Merck

    Reverse Pitch Presentations
  • 10:00am - 10:30am

    Startup Stadium: Aneurisk

    Startup Stadium
  • 1:00pm - 1:20pm

    Reverse Pitch Presentation: UPMC Enterprises

    Reverse Pitch Presentations
  • 10:20am - 10:40am

    Entrepreneur Arena: Glycotest

    Entrepreneur Arena
  • 10:20am - 10:40am

    Reverse Pitch Presentation: Johnson & Johnson

    Reverse Pitch Presentations
  • 10:30am - 11:00am

    Startup Stadium: Heartio

    Startup Stadium
  • 10:40am - 11:00am

    Entrepreneur Arena: BlueSphere Bio

    Entrepreneur Arena
  • 10:40am - 11:00am

    Reverse Pitch Presentation: Children's Hospital of Philadelphia

    Reverse Pitch Presentations
Intermission
Part the Second · For the Buyer

An audience of 39 companies, parsed from the program.

“39 companies in attendance.”

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

№ 01Fig. 01 — Composition of the House
0All threespeak · spons · exh
0Sponsoringsponsor only
0Exhibitingexhibitor only
39Companies Speakingspeaker only
№ 02Fig. 02 — The Voices, by Seniority

80% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1538%
  • Founder / Owner513%
  • VP-level38%
  • Director / Head of923%
  • Manager / Lead13%
  • Advisor / Investor13%
  • Other roles615%

Of 40 on the bill · classified by free-text title

№ 03Fig. 03 — The Heaviest in the Room
  1. 01EY2V
  2. 02BBC Pharma Advisory1V
  3. 03B Braun1V
  4. 04BioForge1V
  5. 05BlueSphere Bio1V
  6. 06Children's Hospital of Philadelphia1V
  7. 07ChyloMetis1V
  8. 08CorriXR Therapeutics1V
  9. 09CytoAgents1V
  10. 10DermaBio1V
  11. 11Drexel University1V
  12. 12dsm-firmenich1V
  13. 13Duane Morris1V
  14. 14F-Prime Capital1V
№ 04Fig. 04 — By Tier

Tiers were not disclosed for this convocation.